Preferred Plus Arthritis Pain
Loading...Preferred Plus Arthritis Pain Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
JUBLIA (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
History
There is currently no drug history available for this drug.
Other Information
JUBLIA (efinaconazole) topical solution, 10% is a clear colorless to pale yellow solution for topical use. Each gram of JUBLIA contains 100 mg of efinaconazole. Efinaconazole is an azole antifungal with a chemical name of ((2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol). The structural formula for efinaconazole is represented below:
JUBLIA contains the following inactive ingredients: alcohol, anhydrous citric acid, butylated hydroxytoluene, C12-15 alkyl lactate, cyclomethicone, diisopropyl adipate, disodium edetate, and purified water.
Sources
Preferred Plus Arthritis Pain Manufacturers
-
Kinray
![Preferred Plus Arthritis Pain (Acetaminophen) Tablet, Film Coated, Extended Release [Kinray]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Preferred Plus Arthritis Pain | Pfizer Animal Health
Administer an initial oral dose of 25 mg/lb (55 mg/kg) of body weight on the first day of treatment. Administer subsequent daily doses at the rate of 12.5 mg/lb (27.5 mg/kg) of body weight. Continue treatment for at least 2 days after remission of clinical signs. Do not extend treatment for more than 21 consecutive days. Suggested dosage schedules follow:
Body Weight (lb)
Up To No. of Tablets
First Day No. of Tablets
Subsequent Days Primor 120 5 1 1/2 10 2 1 15 3 1 1/2 Primor 240 10 1 1/2 20 2 1 30 3 1 1/2 Primor 600 25 1 1/2 50 2 1 Primor 1200 50 1 1/2 100 2 1For optimal therapeutic effect: (1) the drug must be given early in the course of the disease; (2) therapeutically effective levels must be maintained in the body throughout the treatment period; (3) treatment should continue for at least 2 days after remission of clinical signs; and (4) the causative bacterial agents must be sensitive to the drug.
Login To Your Free Account